Theravance Biopharma Said Co's Units, Mylan Ireland Limited & Mylan Specialty L.P. Entered Settlement Deal With Teva Pharmaceuticals, Its Units Regarding Patent Litigation
Portfolio Pulse from Charles Gross
Theravance Biopharma's units, Mylan Ireland Limited & Mylan Specialty L.P., have entered a settlement deal with Teva Pharmaceuticals and its units regarding patent litigation.
October 30, 2023 | 9:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Theravance Biopharma's units have settled a patent litigation with Teva Pharmaceuticals, which could potentially reduce legal costs and risks.
The settlement of the patent litigation could potentially reduce legal costs and risks for Theravance Biopharma, which could have a positive impact on its financial performance and stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Mylan, a unit of Viatris, has settled a patent litigation with Teva Pharmaceuticals, which could potentially reduce legal costs and risks.
The settlement of the patent litigation could potentially reduce legal costs and risks for Viatris, which could have a positive impact on its financial performance and stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70